Newsletters
Document Overview
Notable News in the Life Sciences: 1Q12
| Author: | Alan S. Louie, Ph.D. |
| Document # | HI234881 |
| Published | May, 2012 |
| Document Type | Perspective |
| Number of Pages | 8 |
Overview
This IDC Health Insights Perspective provides an unranked list and assessment of important news and trends reported in January through March 2012. (Note also that progress attained or subsequent news reported after the initial announcement may not be included in these analyses.)
In our lead role as life science industry analysts, IDC Health Insights analysts routinely monitor progress and news from across the life science spectrum. Building from monthly assessments of notable announcements, we believe that clients may find value in news and relevant reported progress that we expect are indications of important trends in the industry. As a result, we are issuing quarterly reports that summarize notable published progress in or affecting the life science industry. This Perspective is the 21st in the series.
Subscriptions Covered:
IDC Health Insights: Clinical Development Strategy and Technology
Companies Covered:
ASTRAZENECA PLC, Pfizer Inc., MERCK SHARP & DOHME CORP., Illumina, Inc.
Regions Covered:
China, United States, Western Europe
Topics Covered:
Vertical Markets:
Our records show that you do not have access to this document.
